欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2041/004
药品名称
Losartan Actavis
活性成分
losartan potassium salt 100.0 mg
剂型
Film-coated tablet
上市许可持有人
Actavis Group PTC ehf Iceland
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
许可日期
2008/04/05
最近更新日期
2023/04/03
药物ATC编码
C09CA01 losartan
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
PI Losartan DK_H_922_01_04 renewal D90 Final CL 020211
Date of last change:2024/09/06
Final SPC
|
PI Losartan DK_H_922_01_04 renewal D90 Final CL 020211_2
Date of last change:2024/09/06
Final SPC
|
PI Losartan DK_H_922_01_04 renewal D90 Final TR 020211
Date of last change:2024/09/06
Final SPC
|
PI Losartan DK_H_922_01_04 renewal D90 Final TR 020211_2
Date of last change:2024/09/06
Final Product Information
|
PI_Losartan_DK_H_922_01_04_P001_v3_2_20171222_CL
Date of last change:2024/09/06
市场状态
Withdrawn(注:已撤市)
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase